baber/WOPTO huggingface dataset:
Patent NZ-512443-A (NZ)
Title: Parallel hydromechanical underdrive transmission
Inventor: TUCKER CLIVE
IPC: F16H47/04
Filed: 1999-11-24
Abstract: A parallel hydromechanical continuously variable transmission has a housing that holds a make-up pump (52), and has internal cavities for holding operating assemblies of the transmission, including an axial piston pump (50) and an axial piston motor (60). The pump (50) and motor (60) each has a rotating element (not shown) and a non-rotating element (not shown). Each non-rotating pump element is mounted for tilting movement on trunnions (not shown) in its own respective pair of mounting journals in the housing. The tilting axes of the non-rotating elements lie transverse to the axes of rotation of the rotating elements. The pump (50) and the motor (60) are disposed side-by-side in the housing with the axes of rotation approximately parallel to each other. A stationary manifold (70), fixed to the housing, has one surface in contact with the rotating pump element (not shown) and a second surface in contact with the rotating motor element (not shown). Fluid passages (not shown) open in the two surfaces in fluid communication with the pump and motor cylinders (206) through a pump/manifold interface. Internal fluid passages (not shown) in the stationary manifold (70) convey fluid pressurized in the pump (50) directly to the motor (60), and convey spent fluid displaced from the motor back to the pump. The transmission ratio is controlled by the tilt angle of the non-rotating pump and motor elements. A tilt angle control apparatus (100) attached to the housing and to the non-rotating pump and motor elements governs that tilt angle.
Patent NZ-513204-A (NZ)
Title: Quinazoline derivatives as angiogenesis inhibitors
Inventor: STOKES ELAINE SOPHIE ELIZABETH
IPC: A61P35/00
Filed: 2000-02-08
Abstract: Compounds of formula (II) and their use in producing an antiangiogenic or vascular permeability-reducing effect in animals.
Patent NZ-517621-A (NZ)
Title: Combined vaccine composition comprising HSV and HPV antigens with a TH1 adjuvant
Inventor: WETTENDORFF MARTINE ANNE CECIL
IPC: E02D3/11
Filed: 2000-09-07
Abstract: A vaccine composition comprising a herpes simplex viral antigen  (HSV) and a human papillomavirus (HPV)  antigen  in conjunction   with  an  adjuvant  which  is  a  preferential stimulator  of  TH1 cell response such as 3D-MPL  and  QS21, and optionally in addition one or more of the following:  an EBV   antigen,   a   hepatitis  A  antigen  or   inactivated attenuated  virus,  a herpes simplex viral  antigen,  a  VZV antigen,  a  HCMV  antigen, a Toxoplasma gondii  antigen  is disclosed.
Patent NZ-518028-A (NZ)
Title: Quinazoline derivatives as VEGF inhibitors
Inventor: HENNEQUIN LAURENT FRANCOIS AND
IPC: C07D401/12
Filed: 2000-11-01
Abstract: The invention relates to quinazoline derivatives of formula (I), wherein m is an integer from 1 to 3; R1 represents halogeno or C1-3alkyl; R2 is selected from one of the following three groups: 1) C1-5alkylR3 (wherein R3 is piperidin-4-yl which may bear one or two substituents selected from hydroxy, halogeno, C1-4alkyl, C1- 4hydroxyalkyl and C1-4alkoxy; 2) C2-5alkenylR3(wherein R3 is as defined hereinbefore); 3) C2-5alkynylR3(wherein R3 is as defined hereinbefore); and wherein any alkyl, alkenyl or alkynyl group may bear one or more substituents selected from hydroxy, halogeno and amino; and salts thereof; processes for their preparation, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent NZ-523615-A (NZ)
Title: Biodegradable or compostable material made from pre-gelled starch suspension and wood fibers and process of forming it
Inventor: BOWDEN JOE A
IPC: B29C43/00
Filed: 2003-01-13
Abstract: A process and materials for forming biodegradable containers that can hold food products in dry, damp or wet conditions are disclosed. The containers are produced through the use of a pre-gelled starch suspension that is unique in its ability to form hydrated gels and to maintain this gel structure in the presence of many other types of materials and at low temperatures. The process disclosed herein for forming a biodegradable material comprises the steps of: (a) forming a pre-gelled starch suspension or paper starch suspension that is maintained between 0 and 60 degree C; (b) mixing together wood fibers or wood flour having an aspect ratio between approximately 1: 2 and 1: 8, water and additional materials selected from the group comprising: (i) dry or damp starch; (ii) pre-gelled starch; (iii) wax, fatty alcohol, phospholipid and/or glycerol; (v) baking powder; and/or (vi) homogenous moldable composition of natural earth fillers, clays, bentonite, amorphous raw products, gypsum or calcium sulfate, minerals such as limestone, and man made materials such as fly-ash to form a homogeneous mixture ; (c) adding to the pre-gelled starch suspension the dry or damp, homogeneous mixture to form a homogenous moldable composition ; and (d) molding the homogenous moldable composition with heat to form a biodegradable material.
Patent NZ-523731-A (NZ)
Title: End-to-end security of transactions between a mobile terminal and an internet server at the application level
Inventor: HUBER ADRIANO
IPC: G07F7/10
Filed: 2000-06-26
Abstract: A  method  for  end-to-end  securing  of  transactions between a mobile terminal (1) and an internet server (5)  at the  application  level,  whereby cryptographic  transaction identification  documents  (91),  destined  for  transaction partner  applications in the mobile terminal (1),  from  the internet  server application are stored (92) for the  mobile terminal  (1), in a proxy server (6).  The proxy server  (6) calculates   a  document  identification  for  each   stored transaction  identification document and  a  document  proxy from  the  corresponding  stored transaction  identification document,  transmits (94) the above to the  mobile  terminal (1), extracts a document identification and a document proxy from  the  information directed (95) to the internet  server application  from the mobile terminal (1). The compatibility (96)  of  the extracted document proxy is checked (97)  with the  document proxy which may be calculated from the  stored transaction  identification document  corresponding  to  the extracted  document  identification  and  where   there   is compatibility  (98)  the  stored transaction  identification document determined by the extracted document identification is transmitted (99) to the internet server application.
Patent NZ-528879-A (NZ)
Title: LNG production in cryogenic natural gas processing plants
Inventor: WILKINSON JOHN D
IPC: F25J3/02
Filed: 2002-04-15
Abstract: A process for liquefying natural gas in conjunction with processing natural gas to recover natural gas liquids (NGL) is disclosed. In the process, the natural gas stream to be liquefied is taken from one of the streams in the NGL recovery plant and cooled under pressure to condense it. A distillation stream is withdrawn from the NGL recovery plant to provide some of the cooling required to condense the natural gas stream. The condensed natural gas stream is expanded (14) to an intermediate pressure and supplied to a mid-column feed point on a distillation column (17). The bottom product (41) from this distillation column (17) preferentially contains the majority of any hydrocarbons heavier than methane that would otherwise reduce the purity of the liquefied natural gas, and is routed to the NGL recovery plant so that these heavier hydrocarbons can be recovered in the NGL product.
Patent NZ-534136-A (NZ)
Title: Process for the manufacture of organic compounds
Inventor: CHEN GUANG-PEI
IPC: C07B53/00
Filed: 2003-01-27
Abstract: Disclosed is an enantioselective method for preparing compounds having formula S1, the method comprising condensing of a disilyloxydiene with an aldehyde in the presence of a titanium (IV) catalyst in an inert solvent.
Patent NZ-536037-A (NZ)
Title: Refined plant transformation
Inventor: WEEKS TROY J
IPC: C12N15/82
Filed: 2003-03-20
Abstract: Provided is a method of producing a transgenic plant comprising as a crucial step vortexing a solution comprising a germinating plant seedling with an Agrobacterium strain for transformation and subsequent growing and screening of transformants. Also provided are similar methods including additionally treatments to induce double stranded DNA breaks in the genome by chemicals or ionizing radiation.
Patent NZ-536062-A (NZ)
Title: Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
Inventor: MORRIS DONALD
IPC: A61K41/00
Filed: 2003-05-08
Abstract: Disclosed are uses of a reovirus to sensitize a neoplastic cell to irradiation. Also provided are methods of treating or ameliorating a tumour using a combination of a reovirus and radiotherapy.
Patent NZ-548482-A (NZ)
Title: Exhaust system for combustion-powered fastener-driving tool
Inventor: DOHERTY JAMES E
IPC: B25C1/08
Filed: 2005-02-02
Abstract: A combustion powered fastener driving tool 10 comprises a single cylinder combustion motor 14. The cylinder comprises an exhaust valve 70 and a piston 24 with an attached driver blade 22. The cylinder defines a path for the piston 24 and the attached driver blade 22, with the piston 24 and the attached driver blade 22 reciprocating between a pre-firing position before the combustion of fuel in the cylinder, and a bottom out position after combustion. The exhaust valve 70 is a check type valve with an exhaust port, and is configured to allow the exhaust of combustion gases from the cylinder but prevent the influx of air into the cylinder thus producing a thermal vacuum after combustion. The exhaust port is dimensioned as a function of the volume of the combustion chamber which is defined in part by the upper edge of the piston, such that sufficient gas is released from the cylinder to reduce the atmospheric pressure in the cylinder to approximately 1 atmosphere in the time it takes for the piston to travel past and return to the exhaust valve.
Patent NZ-552216-A (NZ)
Title: Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
Inventor: ENGLES CHARLES R
IPC: A61K8/00
Filed: 2002-08-16
Abstract: Disclosed is a composition comprising a pharmaceutically or cosmetically acceptable topical carrier and a pharmaceutically or cosmetically effective amount of an aromatic aldehyde selected from the group consisting of 2-ethoxybenzaldehyde, 4-ethoxybenzaldehyde, 4-propoxybenzaldehyde, 4butoxybenzaldehyde, 4-pentyloxybenzaldehyde, and 4-hexyloxybenzaldehyde. (62) (62) Divided out of 532437
Patent NZ-555322-A (NZ)
Title: Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
Inventor: MOSSEL ERIC C
Filed: 2005-10-27
Abstract: Disclosed is the use of an immunomodulator compound of formula (I), wherein the substituents are as defined in the specification, for the treatment of hemorrhagic viral infections.
Patent NZ-556697-A (NZ)
Title: Improvements in or relating to the treatment of multiple sclerosis
Inventor: SMITH CRAIG P
IPC: A61K/
Filed: 2002-02-14
Abstract: N-(Pyridinyl)-1H-indol-1-amines of formula (I) provide a unique combination of blocking properties for both the potassium and sodium channels. Particularly disclosed is a use of the compound of formula (I) in the manufacture of a medicament for treating multiple sclerosis wherein the induction of seizures is avoided; for providing symptomatic relief of spastic paraparesis caused by multiple sclerosis; for providing symptomatic relief of an unsteady gait caused by multiple sclerosis; for providing symptomatic relief of diplopia caused by multiple sclerosis; for treating multiple sclerosis while avoiding the concomitant liability of adverse side-effects (such as restlessness, confusion and seizures) associated with the administration of a compound that increases action potential amplitude and duration in demyelinated nerve fibres; for treating multiple sclerosis while avoiding the concomitant liability of adverse side-effects (such as restlessness, confusion and seizures) associated with the administration of an antagonist of voltage-dependent potassium channels; for treating multiple sclerosis while avoiding the concomitant liability of adverse side-effects (such as restlessness, confusion and seizures) associated with the administration of a compound that acts to block the potassium channel; for enhancing neuronal conduction in a patient afflicted with multiple sclerosis while avoiding the concomitant liability of seizures associated with administration of a voltage-dependent potassium channel antagonist; for improving locomotor function in a patient afflicted with multiple sclerosis while avoiding the concomitant liability of seizures associated with administration of a voltage-dependent potassium channel antagonist; for improving the walking ability of a patient afflicted with multiple sclerosis; for improving walking ability in a patient afflicted with multiple sclerosis while avoiding the concomitant liability of seizures associated with administration of a voltage-dependent potassium channel antagonist; for treating multiple sclerosis, wherein the medicament comprises an amount of the compound that is sufficient to treat multiple sclerosis but insufficient to cause seizures; and for improving the walking ability of a patient afflicted with multiple sclerosis, wherein the medicament comprises an amount of the compound that is sufficient to treat multiple sclerosis but insufficient to cause seizures.
Patent NZ-563341-A (NZ)
Title: Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
Inventor: HORNER ALLISON ANNE BYERS
IPC: A01K67/027
Filed: 2006-05-18
Abstract: Disclosed are methods for identifying an agent that modulates a phenotype associated with a disruption of a gene which encodes for a PRO1568 polypeptide, comprising the administration of a test agent to transgenic animal whose genome comprises a disruption of the aforementioned gene and wherein the phenotype is an eye abnormality or a renal disease. Further disclosed is the use of an antagonists or agonists of a PRO1568 polypeptide for the manufacture of a medicament for the treatment or prevention of an eye abnormality or renal disease.
Patent NZ-567278-A (NZ)
Title: Concrete slabs for roads with size so that only one wheel/set ot truck wheels supported at a time
Inventor: COVARRUBIAS TORRES JUAN PABLO
IPC: E01C11/02
Filed: 2006-07-27
Abstract: An active respiratory therapeutic device for clearing breathing passages, loosening and breaking up mucus plugs and phlegm in a patient's sinuses, trachea, bronchial passages and lungs while a patient is breathing normally through the device is disclosed. The apparatus preferably includes a C shaped curved hollow housing having a closed end portion and an open threaded end portion. The open end portion forms at least part of an acoustic coupling chamber. A generally funnel shaped tapered mouthpiece tapers to a small end portion sized to be inserted into a patient's mouth. The mouthpiece forms another part of the acoustic coupling chamber. An acoustic signal generator housed within the hollow housing generates and directs acoustic vibrations into and through the coupling chamber.; The mouthpiece preferably includes a valve permitting a patient breathing through the mouthpiece to inhale through a valve opening and exhale through a bypass passage around the valve while at the same time coupling the acoustic coupling chamber into the patient's airways. An acoustic seal is provided to reduce noise generated by the acoustic generator.
Patent NZ-569517-A (NZ)
Title: Use of KCNQ-openers for threating or reducing the symptoms of schizophrenia
Inventor: HUSUM BAK-JENSEN HENRIETTE
IPC: A61P25/18
Filed: 2007-02-02
Abstract: Disclosed is the use of an aryl amine in the manufacture of a medicament for treating or reducing the symptoms of schizophrenia, wherein the compound is of formula 1: wherein R1, R2 and R2', R3 and Y are defined in the specification, X is CO or SO2, and q is 0 or 1; or a pharmaceutically acceptable salt thereof.
Patent NZ-577047-A (NZ)
Title: Mapk/erk kinase inhibitors
Inventor: DONG QING
IPC: A61K31/513
Filed: 2007-10-22
Abstract: Disclosed is a compound, wherein the substituents are as defined in the specification. The compounds are MAPK/ERK Kinase inhibitors useful in the treatment of cancerous hyperproliferative disorders; non-cancerous hyperproliferative disorders; pancreatitis; kidney disease; pain; preventing blastocyte implantation; treating diseases related to vasculogenesis or angiogenesis; asthma; neutrophil chemotaxis; septic shock; T-cell mediated diseases where immune suppression would be of value; atherosclerosis; and inhibition of keratinocyte responses to growth factor cocktails.
Patent NZ-580649-A (NZ)
Title: Metal, preferably steel stud and panel system for filling with concrete
Inventor: BENNETT ALISTER
IPC: E04B2/86
Filed: 2008-04-01
Abstract: A stud system for 1 use in a formwork having two spaced apart outer wall sheets 2a, 2b comprises at least one elongate stud 4, and one or more elongate reinforcing strips 10, where the stud 4 has a longitudinally extending web 5 with two opposite side edges, first and second longitudinally extending side wall s 7a, 7b with each of the side walls having a first side edge 8a and an opposite second side edge 8b. The first side edges 8a of the side walls 7a, 7b are joined to the respective side edges of the web 5, such that the side walls 7a, 7b extend substantially perpendicularly to the web 5 with each side wall having an outer wall surface and an inner wall surface, with the inner wall surfaces of the two side walls 7a, 7b facing each other. Each side wall has a longitudinally extending flange 9. The flange 9 has a first side edge and an opposite second side edge, with the first side edge of the first flange joined to the second side edge of the first side wall 7a and the first side edge of the second flange joined to the second side edge of the second side wall 7b, such that the flanges 9 extend from the side walls towards each other substantially parallel to the web 5, with the second side edges of the flange being spaced from each other. The outer surface of each side wall of the stud 4 is adapted to be joined face-to-face to a respective outer sheet such that the web spans the distance between the outer wall sheets 2a, 2b. The second edges of the stud flanges 9 are adapted to allow securing of the opposite ends of the reinforcing members 10. The stud 4 defines a first and second inner wall with each inner wall having a first side edge and an opposite second side edge. The first side edge of the first inner wall 18a is joined to the second side edge of the first flange 9 and the first side edge of the second inner wall 18b is joined to the second side edge of the second flange 9, such that the inner walls 18a, 18b extend from the flanges 9 towards the web 5 substantially parallel to the side walls, with the second side edges of the inner walls 18a, 18b being spaced from the web 5. The stud system further comprises a first and a second lip 11, joined to, and extending from, the second side edges of the first inner wall and second inner wall respectively, towards the first side wall and second side wall respectively.
Patent NZ-583228-A (NZ)
Title: Cleaning in membrane filtration systems
Inventor: JOHNSON WARREN THOMAS
IPC: B01D65/02
Filed: 2005-12-19
Abstract: Disclosed is a method of controlling a chemical clean of a membrane comprising: measuring pH and/or membrane resistance of a membrane for at least a portion of said clean; and ceasing said chemical clean when pH and/or membrane resistance attains a predetermined value. Also disclosed is a method of controlling a chemical clean of a membrane comprising: measuring pH and/or membrane resistance of a membrane for at least a portion of said clean; measuring elapsed time of the clean; calculating a rate of change of pH with respect to time (dpH/dt) and/or a rate of change of membrane resistance (dR/dt) with respect to time; and ceasing said chemical clean when dpH/dt and/or dR/dt attains a predetermined value.
Patent NZ-586599-A (NZ)
Title: Mirror indicia for jerk handle inflator
Inventor: FAWCETT LYMAN W JR
IPC: A41D13/012
Filed: 2004-09-08
Abstract: The jerk handle 10 for a lanyard 17 of an inflator is provided with mirror image openings in the thin planar indicia portion 12A of the body of the handle which form mirror image indicia which are visible from the respective opposite sides of the body. The indicia may be in the form of icons, symbols, characters or words such as the arrow and words JERK TIRER.
Patent NZ-588410-A (NZ)
Title: Fire detection system comprising a sensing device that actuates according to physical conditions of a sensing fluid
Inventor: SMITH PAUL D
IPC: G08B17/04
Filed: 2010-10-06
Abstract: A fire detection system (10) is disclosed. The system (10) comprises a detection tube (22) containing a sensing fluid (23) having a first physical condition and a second physical condition. The sensing fluid (23) achieves the first physical condition below a temperature threshold and achieves the second physical condition above the temperature threshold and at an increased pressure. The detection tube (22) forms a restricted volume and the sensing fluid (23) is inescapably sealed within the detection tube (22). The detection tube (22) is also reusable through multiple cycles of physical changes. The detection system (10) further comprises a sensing device (16). The sensing device (16) is movable to open in response to a transition of a portion of the sensing fluid (23) from the first physical condition to the second physical condition. Similarly, the sensing device (16) is movable from open in response to the transition of a portion of the sensing fluid (23) from the second physical condition to the first physical condition. The movement of the sensing device (16) to open causes the release of fire suppressant (13) from the system (10).
Patent NZ-588604-A (NZ)
Title: Swing handle lockable to support frame by passing securing means through passageways
Inventor: STUCKEY DAVID MARTIN
IPC: E05B17/00
Filed: 2009-05-07
Abstract: A swing handle assembly (500) comprising a swing handle member (510) and a supporting frame (520) therefore where when the handle member substantially contacts the frame, the handle assembly is in a closed condition. The handle member (510) comprises at least an outer surface (511) and two side walls (512), each side wall including an opening (513) therein wherein the openings are substantially aligned to define a passageway (513) through the handle member. The supporting frame (520) bears a capture means (521), which capture means is substantially receivable within the handle member and is in substantial alignment with the passageway therethrough when the handle assembly is in the closed condition, such, that to then place the handle assembly in a locked condition, a separate securing means (not show but typically a padlock) is able to be passed through the passageway and the capture means.
Patent NZ-594209-A (NZ)
Title: Security pouch with an indicator layer which produces a colour change in the event of mechanical damage
Inventor: HENNEK HEINRICH
IPC: B65D33/34
Filed: 2010-01-11
Abstract: A security pouch (10) made of plastic, which is used to receive and transport valuables. The security pouch has a lower (11) and an upper plastic layer (12), which are joined to each other, forming a closable access opening (16). The security pouch is provided with a single-layer or multi-layer indicator layer (17), which produces a color change in the event of mechanical damage and in particular slitting.